Membranous nephropathy (MN) is a rare autoimmune kidney disease. Most autoimmune diseases are associated with a pro-inflammatory Th17-immune response, but little is known about immune dysregulation in MN. In China, MN was associated with exposure to fine air particulate matter (PM2.5) that could act as a danger signal and redirect immune...
-
March 5, 2021 (v1)PublicationUploaded on: December 4, 2022
-
November 26, 2020 (v1)Journal article
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
Uploaded on: February 22, 2023 -
September 1, 2021 (v1)Book section
Exciting times for the field of renal autoimmune diseases have begun. In 2021, for the first time, two new drugs belimumab (1) and voclosporin ( 2) are approved for the treatment of lupus nephritis (LN) (1, 2). Other novel targeted therapies demonstrate clinical efficacy in large, randomized trials, such as avacopan for ANCA-associated...
Uploaded on: December 4, 2022 -
November 26, 2020 (v1)Journal article
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
Uploaded on: December 4, 2022 -
November 2023 (v1)Journal article
International audience
Uploaded on: December 6, 2023 -
September 2024 (v1)Journal article
IntroductionMembranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival.MethodsWe conducted a prospective multicenter study in France involving 72 patients with membranous nephropathy who were awaiting and then...
Uploaded on: September 27, 2024